LMC Diabetes & Endocrinology Ltd.
🇨🇦Canada
Clinical Trials
20
Active:1
Completed:12
Trial Phases
2 Phases
Phase 4:5
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (50.0%)Phase 4
5 (50.0%)REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring When Added to Low-calorie Meal Replacement and Diabetes Self-management Education
Not Applicable
Not yet recruiting
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2025-09-05
- Last Posted Date
- 2025-09-05
- Lead Sponsor
- LMC Diabetes & Endocrinology Ltd.
- Target Recruit Count
- 176
- Registration Number
- NCT07157384
- Locations
- 🇨🇦
LMC Brampton, Brampton, Ontario, Canada
🇨🇦LMC Etobicoke, Etobicoke, Ontario, Canada
🇨🇦LMC Oakville, Oakville, Ontario, Canada
Real-world Effect of Switching From Intermittently-scanned to Real-time Continuous Glucose Monitoring (Switch CGM Retro)
Completed
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- LMC Diabetes & Endocrinology Ltd.
- Target Recruit Count
- 220
- Registration Number
- NCT06962735
- Locations
- 🇨🇦
LMC Diabetes & Endocrinology Ltd., Toronto, Ontario, Canada
Real-world Effects of Using Intermittently Scanned Continuous Glucose Monitoring and Pharmacist-led Coaching on the Management of Type 2 Diabetes Among Adults Not Using Insulin (REAL isCGM T2D)
Recruiting
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2025-02-20
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- LMC Diabetes & Endocrinology Ltd.
- Target Recruit Count
- 250
- Registration Number
- NCT06837103
- Locations
- 🇨🇦
LMC Diabetes & Endocrinology Ltd., Toronto, Ontario, Canada
Effect of Switching From Intermittently Scanned to Real-time Continuous Glucose Monitoring on Diabetes Management in Adults With Type 2 Diabetes (Switch CGM T2D)
Recruiting
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- LMC Diabetes & Endocrinology Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT06805786
- Locations
- 🇨🇦
LMC Diabetes & Endocrinology Ltd., Toronto, Ontario, Canada
Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease
Completed
- Conditions
- Type 2 DiabetesChronic Kidney Diseases
- Interventions
- Drug: GLP-1 receptor agonist
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- LMC Diabetes & Endocrinology Ltd.
- Target Recruit Count
- 348
- Registration Number
- NCT06236672
- Locations
- 🇨🇦
LMC Diabetes & Endocrinology Ltd., Toronto, Ontario, Canada
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found